Future studies could use a parallel group of tumor-bearing mice treated with M002 to quantify the infiltrating CD8+ cell population by flow cytometry and potentially explore kinetics of CD8+ cell infiltration, albeit this requires many mice and does not allow for longitudinal evaluation in the same mouse. The gene discussed is CD8A; the disease is neoplasm.